We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of FRTX yet.

FRTX Hedge Fund Activity: Q2 2024 in Review

0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2024, worth a combined $0 — down 100% from $40 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of FRTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Old Point Trust & Financial Services N A, exiting entirely with an estimated $40 sold.

  • 0 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2024, down from 1 in Q1 2024.
  • Funds reported $0 of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2024 was Old Point Trust & Financial Services N A, an estimated $40 sold.

Based on aggregated 13F filings for Q2 2024.